Printer Friendly

Mendel obtains United States patent.

Mendel Biotechnology, Inc. (Hayward, CA) has patented compositions and methods for modifying a trait of a plant. Isolated polynucleotide and polypeptide sequences are provided, along with an expression vector comprising the isolated polynucleotide, a host cell comprising the isolated polynucleotide, and a transgenic plant comprising the isolated polynucleotide. Also provided is a method for producing a transgenic plant, a method for screening for a compound that may modify the trait and a method for identifying other homologous polynucleotide and polypeptide sequences. (US 7,223,904)
COPYRIGHT 2007 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Date:May 1, 2007
Previous Article:Forest Laboratories and Cypress Bioscience announce positive results of Phase III study for milnacipran as a treatment for fibromyalgia syndrome.
Next Article:Yissum obtains United States patent.

Related Articles
Biolog granted gene function patent.
Metabasis Therapeutics patents technology for teating liver disease.
Arena Pharmaceuticals receives United States patent.
Hoffmann-La Roche $1 billion lawsuit filed by Promega.
Seminar examines biotech concerns.
MorphoSys widens scope of United States patent for HuCAL technology.
Yulex (, Maricopa, AZ, the United States Department of Agriculture's Agricultural Research Service (USDA-ARS) and Mendel Biotechnology...
Monsanto increases its investment in Mendel Biotechnology, Inc., one of the company's key collaborators on agriculture technologies.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters